|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1998-10-20
|
|
pubmed:abstractText |
Because selective serotonin reuptake inhibitors (SSRIs) require 2-4 weeks to reach efficacy, the authors determined whether clonazepam augmentation of fluoxetine is superior to fluoxetine alone at the beginning of treatment for major depression.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0002-953X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
155
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1339-45
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9766764-Adult,
pubmed-meshheading:9766764-Ambulatory Care,
pubmed-meshheading:9766764-Clonazepam,
pubmed-meshheading:9766764-Depressive Disorder,
pubmed-meshheading:9766764-Double-Blind Method,
pubmed-meshheading:9766764-Drug Administration Schedule,
pubmed-meshheading:9766764-Drug Therapy, Combination,
pubmed-meshheading:9766764-Fluoxetine,
pubmed-meshheading:9766764-GABA Modulators,
pubmed-meshheading:9766764-Humans,
pubmed-meshheading:9766764-Patient Compliance,
pubmed-meshheading:9766764-Placebos,
pubmed-meshheading:9766764-Psychiatric Status Rating Scales,
pubmed-meshheading:9766764-Serotonin Uptake Inhibitors,
pubmed-meshheading:9766764-Severity of Illness Index,
pubmed-meshheading:9766764-Suicide
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study.
|
|
pubmed:affiliation |
Summit Research Network, Portland, Ore. 97209, USA. wsmith@summitnetwork.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
